1.
Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease
by Campbell, Duncan J
Hypertension (Dallas, Tex. 1979), 2005-01, Vol.45 (1), p.69-74

2.
Differences between blood-pressure-lowering drugs
by MacMahon, Stephen
The Lancet (British edition), 2000, Vol.356 (9227), p.352-353

3.
An Economic Evaluation of a Perindopril-Based Blood Pressure Lowering Regimen for Patients Who Have Suffered a Cerebrovascular Event
by Tavakoli, Manouchehr
The European journal of health economics, 2009-02-01, Vol.10 (1), p.111-119

4.
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition
by HARRAP, Stephen B
Hypertension (Dallas, Tex. 1979), 2003, Vol.42 (3), p.297-303

5.
The lowering of blood pressure after stroke
by MacMahon, Stephen
The Lancet (British edition), 2001-12-08, Vol.358 (9297), p.1994-1995

6.
Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor-Based Regimens An Individual Patient Data Meta-Analysis From Randomized, Placebo-Controlled Trials
by Bell, Katy J. L
Hypertension (Dallas, Tex. 1979), 2010-09, Vol.56 (3), p.533-U429

7.
The lowering of blood pressure after stroke
by Cates, Christopher
The Lancet (British edition), 2001-12-08, Vol.358 (9297), p.1993-1993
